Anti-Human JAM-A/CD321 Rabbit Recombinant Antibody

JAM-A/CD321 Uni-rAbTM Recombinant Antibody for FC
Cat No. 98328-3-RR
Clone No.242290B3

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

FC

F11R, JAM-A/Junctional Adhesion Molecule A, 242290B3, CD321, F11 receptor

Formulation:  PBS and Azide
PBS and Azide
PBS Only
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive FC detected inhuman peripheral blood leukocytes

Recommended dilution

ApplicationDilution
Flow Cytometry (FC)FC : 0.25 ug per 10^6 cells in 100 μl suspension
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

98328-3-RR targets JAM-A/CD321 in FC applications and shows reactivity with human samples.

Tested Reactivity human
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen JAM-A/CD321 fusion protein Eg1372 Predict reactive species
Full Name F11 receptor
Calculated Molecular Weight33kDa
GenBank Accession NumberNM_016946.6
Gene Symbol F11R
Gene ID (NCBI) 50848
Conjugate Unconjugated
Form Liquid
Purification MethodProtein A purification
UNIPROT IDQ9Y624-1
Storage Buffer PBS with 0.09% sodium azide, pH 7.3.
Storage ConditionsStore at 2 - 8°C. Stable for one year after shipment.

Background Information

Junctional adhesion molecule A (JAM-A), also known as CD321 or F11 receptor (F11R), was first identified in human platelets as a 32/35 kDa protein duplex that serves as the receptor for a functional antibody that activates platelets. It seems to play a role in epithelial tight junction formation. It was also reported to function as a receptor for reovirus and a ligand for the integrin LFA1.

Protocols

Product Specific Protocols
FC protocol for JAM-A/CD321 antibody 98328-3-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...